Evaluating Pharmacists’ Pharmacological Knowledge and Views Regarding Pfizer-BioNTech COVID-19 Vaccine in Saudi Arabia

BACKGROUND: The Pfizer-BioNTech COVID-19 vaccine has been widely used and approved for the prevention of 2019 coronavirus disease (COVID-19) for individuals aged 16 years and older in Saudi Arabia. The emergency use authorization of this vaccine is crucial to managing the pandemic in the Kingdom. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Alorfi, Nasser, Ashour, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994594/
https://www.ncbi.nlm.nih.gov/pubmed/35411192
http://dx.doi.org/10.2147/CPAA.S356413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994594/
https://www.ncbi.nlm.nih.gov/pubmed/35411192
http://dx.doi.org/10.2147/CPAA.S356413

Ejemplares similares